共 37 条
- [31] Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin): study protocol for a randomized controlled trialTrials, 15Sam McClintonKathryn StarrRuth ThomasGraeme McLennanGladys McPhersonAlison McDonaldThomas LamJames N’DowMary KilonzoRobert PickardKen AnsonJennifer Burr
- [32] Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studiesWORLD JOURNAL OF UROLOGY, 2014, 32 (05) : 1119 - 1125Eisenhardt, AndreasSchneider, TimCruz, FranciscoOelke, Matthias
- [33] Editorial Comment to Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and KoreaINTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (07) : 676 - 676Akino, Hironobu
- [34] Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in EuropeEUROPEAN UROLOGY, 2011, 59 (03) : 342 - 352Chapple, Christopher R.Montorsi, FrancescoTammela, Teuvo L. J.Wirth, ManfredKoldewijn, EvertFernandez Fernandez, Eldiberto
- [35] Hemodynamic Effects of Once-daily Tadalafil in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant α1-Adrenergic Antagonist Therapy: Results of a Multicenter Randomized, Double-Blind, Placebo-controlled TrialUROLOGY, 2012, 79 (04) : 875 - 882Goldfischer, EvanKowalczyk, John J.Clark, William R.Brady, ErinShane, Michael AnneDgetluck, NancyKlise, Suzanne R.
- [36] Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placeboINTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 582 - 587Roehrborn, Claus G.Casabe, AdolfoGlina, SidneySorsaburu, SebastianHenneges, CarstenViktrup, Lars
- [37] Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trialsINTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (12) : 1496 - 1507Vlachopoulos, C.Oelke, M.Maggi, M.Mulhall, J. P.Rosenberg, M. T.Brock, G. B.Esler, A.Buettner, H.